TrialOrphanet journal of rare diseases2024

Caregiver experiences and observations of intrathecal idursulfase-IT treatment in a phase 2/3 trial in pediatric patients with neuronopathic mucopolysaccharidosis II.

Karen S Yee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.